<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for VICL</title>
    <link />
    <description>Headlines for Vical, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Interesting VICL Put And Call For July</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11928571/1/interesting-vicl-put-and-call-for-july.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Mon, 20 May 2013 15:24:00 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11926178/1/biotech-stock-mailbag-vical-sangamo-spectrum-pharma.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 17 May 2013 07:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Vical's CEO Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript)</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1435511-vical-s-ceo-presents-at-bank-of-america-merrill-lynch-2013-health-care-conference-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 14 May 2013 23:35:06 GMT</pubDate>
    </item>
    <item>
      <title>Short Interest In Vical Moves 21.2% Higher</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11920447/1/short-interest-in-vical-moves-212-higher.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Fri, 10 May 2013 15:33:00 GMT</pubDate>
    </item>
    <item>
      <title>Vical's CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1420941-vical-s-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 09 May 2013 16:32:02 GMT</pubDate>
    </item>
    <item>
      <title>Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1399261-undervaluation-of-vical-s-full-pipeline-allows-a-cheap-bet-on-cancer-trial.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 03 May 2013 12:15:10 GMT</pubDate>
    </item>
    <item>
      <title>A Tale Of Three Pharmaceuticals: Getting Exciting In 2013</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1381501-a-tale-of-three-pharmaceuticals-getting-exciting-in-2013.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 29 Apr 2013 12:53:22 GMT</pubDate>
    </item>
    <item>
      <title>Melanoma: Battle Of 3 Cancer Vaccines</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1362181-melanoma-battle-of-3-cancer-vaccines.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 23 Apr 2013 13:25:30 GMT</pubDate>
    </item>
    <item>
      <title>Companies Focused On Cancers Of The Epidermal Layers May Yield Profits</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1356021-companies-focused-on-cancers-of-the-epidermal-layers-may-yield-profits.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sat, 20 Apr 2013 13:29:59 GMT</pubDate>
    </item>
    <item>
      <title>6 Stocks Under $10 Spiking Higher</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/6-stocks-under-10-spiking-higher.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 04 Apr 2013 14:58:00 GMT</pubDate>
    </item>
    <item>
      <title>Amgen's And Vical's Melanoma Trials: Questions</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1304411-amgen-s-and-vical-s-melanoma-trials-questions.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 27 Mar 2013 13:26:17 GMT</pubDate>
    </item>
    <item>
      <title>Recent Melanoma Trial Data Has Biotech Stocks Moving</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1302841-recent-melanoma-trial-data-has-biotech-stocks-moving.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 27 Mar 2013 01:52:52 GMT</pubDate>
    </item>
    <item>
      <title>Here's What This 220% Gainer Has Been Buying and Selling</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/18/heres-what-this-220-gainer-has-been-buying-and-s/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 18 Mar 2013 22:34:00 GMT</pubDate>
    </item>
    <item>
      <title>5 of Last Week's Biggest Winners</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/10/5-of-last-weeks-biggest-winners-24/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 10 Mar 2013 08:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Whoa! These 3 Stocks Easily Beat the Dow</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/07/whoa-these-3-stocks-easily-beat-the-dow/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 07 Mar 2013 22:08:00 GMT</pubDate>
    </item>
    <item>
      <title>Buy, Sell, or Hold: Vical</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/25/buy-sell-or-hold-vical/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 25 Feb 2013 10:01:00 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Could Rise For Companies Investing In Immunotherapy Treatments</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1201001-stocks-could-rise-for-companies-investing-in-immunotherapy-treatments.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 18 Feb 2013 14:16:05 GMT</pubDate>
    </item>
    <item>
      <title>3 Events Biotech Investors Need to Watch in 2013</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/13/3-events-biotech-investors-need-to-watch-in/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 13 Feb 2013 15:08:00 GMT</pubDate>
    </item>
    <item>
      <title>Vical's Loss Narrower than Expected - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/92374/vicals-loss-narrower-than-expected.aspx</link>
      <author>Zacks</author>
      <pubDate>Fri, 08 Feb 2013 16:22:01 GMT</pubDate>
    </item>
    <item>
      <title>Vical's CEO Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1166971-vical-s-ceo-discusses-q4-2012-results-earnings-call-transcript.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 07 Feb 2013 21:57:03 GMT</pubDate>
    </item>
  </channel>
</rss>
